About 300 reports

The company has received approval for tbo-filgrastim (XM## filgrastim).

  • Targeted Therapy
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

TABLE OF CONTENTS (##/ ##) ##.

  • Targeted Therapy
  • Therapy
  • World
  • Supply
  • Remicade group
  • The following compounds are being studied as potential biosimilars:
  • BIOSIMILARS: MABS & BIOLOGICS PIPELINE

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Targeted Therapy
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

In the supportive care space, several filgrastim (Amgen' s Neupogen) biosimilars are already marketed in the ##MM.

  • Targeted Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Gland Surgery; ##(##): ##-## Zhang P, et al. (2016).

  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Binocrit (epoetin alfa Zarzio/ Zarxio (filgrastim) Used in therapy area of Hematology. neutropenia after chemotherapy.

  • Biopharmaceutical
  • Targeted Therapy
  • Therapy
  • World
  • Market Size

" Cost to patients is the number one issue [unmet need], number one. "

  • Targeted Therapy
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • United States
  • Demand
  • AstraZeneca PLC
  • Roche Group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • Therapy
  • United States
  • Demand
  • Amgen Inc.

Neupogen (filgrastim) ##.

  • Chemotherapy
  • Targeted Therapy
  • North America
  • United States
  • Roche Group

IN MARCH 2015, THE US FDA APPROVED THE FIRST BIOSIMILAR, ZARXIO (FILGRASTIM BIOSIMILAR), AND IS CURRENTLY IN THE PROCESS OF FORMALIZING INDUSTRY GUIDANCE FOR BIOSIMILAR DEVELOPMENT (FDA, PRESS RELEASE, MARCH ##, 2015).

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

NEUPOGEN (FILGRASTIM) ##.

  • Chemotherapy
  • Targeted Therapy
  • North America
  • United States
  • Roche Group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • North America
  • United States
  • Biocon Limited
  • Roche Group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • United States
  • AstraZeneca PLC
  • Pfizer Inc.
  • Roche Group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • United States
  • Demand
  • Gilead Sciences, Inc.
  • Roche Group

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • United States
  • Demand
  • Genmab group
  • Janssen Biotech, Inc.

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • North America
  • United States
  • ARIAD Pharmaceuticals, Inc.
  • Incyte Corporation
  • TOP SELLING BIOLOGICS: ESTIMATED PATENT EXPIRY
  • BEST SELLING BIOLOGICS: REVENUES

FILGRASTIM ##. ##. ##.

  • Targeted Therapy
  • North America
  • United States
  • Market Size
  • Sandoz Inc.

PLoS One; ##(##): epub ACR (2013).

  • Targeted Therapy
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • North America
  • United States
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Neupogen (filgrastim) ##.

  • Targeted Therapy
  • Therapy
  • United States
  • Demand
  • Celgene Corporation
  • 8.2 ALL PIPELINE DRUGS BY PHASE OF DEVELOPMENT

PLoS One; ##: ##-## Siddiqui M and Perry CM (2012).

  • Targeted Therapy
  • World
  • Market Size
  • Celgene Corporation
  • Merck & Co., Inc.

ua: ##.

  • Targeted Therapy
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

MARKET ##.

  • Targeted Therapy
  • Vaccine
  • APAC
  • World
  • Market Size

Skin Therapy Letter; ##(##): ##-##.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Skin Therapy Letter; ##(##): ##-##.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Nutrasource FemMED Breast Health Formula ferumoxytol Fibromun AMAG Philogen ficlatuzumab AVEO Monoclonal antibody figitumumab Pfizer Monoclonal antibody filgrastim biosimilar finasteride Sandoz Merck.

  • Targeted Therapy
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Amgen Inc. ## ## ## ## ## ## ## ## AbbVie Inc. ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2015 2015 trials are taken as of Augu

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.